Signal Transduction and Targeted Therapy?(ISSN 2059-3635 (online), ISSN 2095-9907 (print), CN 51-1758/R) is a new open access journal, which aims to accomplish timely publication of the latest discoveries and progress in both basic science and clinical research related to signal transduction and targeted therapy. It will include research on major human diseases, particularly on cancer.?

Signal Transduction and Targeted Therapy?is a multidisciplinary journal, covering topics including but not limited to molecular biology, cell biology, pharmacology, medicinal chemistry, computational chemistry, systems biology, bioinformatics, and clinical medicine.

The editorial team of?Signal Transduction and Targeted Therapy?is composed of a highly respected editorial board of researchers from across the globe, led by the internationally renowned?Professor Carlo M. Croce, together with?Professor Kang Zhang?and?Professor Yu-Quan Wei.

This journal is now indexed in Pubmed Central (PMC) , Scopus, Directory of Open Access Journals (DOAJ) and?BIOSIS.

Disclaimer

The editorial policies of this publication are determined jointly by its Editorial Board and Springer Nature in accordance with the legal and regulatory requirements of China.